HIV/AIDS leading cause of premature death in Thailand – study

BANGKOK (Thomson Reuters Foundation) – HIV/AIDS is the leading cause of premature death and disability from disease in Thailand and the death toll is rising in some other Southeast Asian countries, findings from a new U.S. study published on Wednesday showed.

While the epidemic in Thailand and elsewhere in Southeast Asia is not nearly as severe as that in sub-Saharan Africa, the problem is significant, especially because HIV/AIDS largely affects young adults, the study by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington said.

The study, which appeared in the peer-reviewed journal AIDS, examines the impact of HIV/AIDS in terms of “disability-adjusted life years”, a measurement which combines years of life lost to premature death with years lived with disability.

Thin Lei Win
Trust
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below